Showing results (141-150 of 370) with videos related to

Sort By:
Pageof 37
Digestive Diseases and Sciences|January 20, 2021
Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and AtherosclerosisT D Filippatos, K Alexakis, V Mavrikaki, et al.
International Angiology : a Journal of the International Union of Angiology|September 1, 1994
Diminished platelet yield and enhanced platelet aggregability in platelet-rich plasma of peripheral vascular disease patientsM A Barradas, G Stansby, G Hamilton, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|October 17, 2009
Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and managementK Tziomalos, V G Athyros, A Karagiannis, et al.
Platelets|November 4, 2010
Evidence for in vivo Platelet Activation Following the Injection of Conventional Unfractionated HeparinD P Mikhailidis, M A Barradas, S O'donoghue, et al.
Diabetes Research (Edinburgh, Scotland)|July 1, 1990
The effect of a slow release formulation of bezafibrate on lipids, glucose homeostasis, platelets and fibrinogen in type II diabetics: a pilot studyS Mathur, M A Barradas, D P Mikhailidis, et al.
International Journal of Clinical Practice|March 21, 2013
Comparison of switch to the highest dose of rosuvastatin vs. add-on nicotinic acid vs. add-on fenofibrate for mixed dyslipidaemiaA Kei, E N Liberopoulos, D P Mikhailidis, et al.
In Vivo (Athens, Greece)|November 1, 1993
Effect of naftidrofuryl and aspirin on platelet aggregation in peripheral vascular diseaseM A Barradas, G Stansby, G Hamilton, et al.
Current Opinion in Cardiology|May 7, 2020
Multifocal arterial disease: clinical implications and managementK I Paraskevas, G Geroulakos, F J Veith, et al.
Current Medical Research and Opinion|June 18, 2004
Uric acid levels and vascular diseaseS S Daskalopoulou, V G Athyros, M Elisaf, et al.
International Angiology : a Journal of the International Union of Angiology|September 5, 2001
The in vitro effect of a low molecular weight heparin, nadroparin (Fraxiparine), on leukocytes obtained from patients with vascular diseasesM Neagu, G Manda, C Constantin, et al.
Pageof 37